Nebenwirkungen · Thalidomide BMS (previously Thalidomide Celgene)
Thalidomide BMS 50 mg hard capsules · Abschnitt 4.8 · PDF-Seite 14
HOS-118569 · Präparat HOS-094839
Posterior reversible encephalopathy syndrome (PRES)/Reversible posterior leukoencephalopathy syndrome (RPLS) Cases of PRES/RPLS have been reported. Signs and symptoms included visual disturbance, headache, seizures and altered mental status, with or without associated hypertension. A diagnosis of PRES/RPLS requires confirmation by brain imaging. The majority of the reported cases had recognized risk factors for PRES/RPLS, including hypertension, renal impairment and concomitant use of high dose corticosteroids and/or chemotherapy.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-01-22T16:42:00Z · SHA-256 537c04bf4162671fd0a63561bed97ea3a0b2ca75db8df09543c26a61de067575 · Passage ca90a14778d881be40e010e1b67ab07961ca7d14f3fc67b98d5a7006a466ed47 · Zeichen 9577–10113 im Abschnitt